Tag ~biotechnologies

Tag descriptions coming soon to Wherrelz News!


Inside the Adaptive Biotech IPO: How two brothers built a big idea into a breakthrough company

Adaptive Biotechnologies posts 263M in Q3 revenue inks partnership with GlaxoSmithKline

Tech Moves: Adaptive Biotech hires commercial officer Instacart names new president and more

Adaptive plans fall launch of Tcell test for past COVID19 detection as alternative to antibody tests

Tech Moves: Xnorai taps former Auth0 leader as CEO Microsoft adds first CVP of retail and more

Tech Moves: Amazons director of Alexa Trust BECU adds CIO Lockstep Fabric exit stealth mode

Adaptive Biotechnologies will triple size of its Seattle HQ following IPO

Microsoftbacked universal blood test could start diagnosing disease within a small number of years

Cellink Subsidiary Cytena to Launch World Changing SingleCell Technology

IPO filing: Microsoft invested 45M in Adaptive Biotechnologies as part of universal blood test deal

Andreessen Horowitz backs Synonyms biomanufacturing facilities

Tech Moves: GE Healthcare exec joins Microsoft Puppet names new CTO Adaptive Biotech expands

Microsoft partners with Adaptive Biotech on AIdriven blood test to diagnose dozens of diseases at once

Adaptive Biotechnologies shares drop as loss widens in first quarterly earnings since IPO

Inside the quest for a new COVID19 test: Microsoft Adaptive Biotech and the hidden power of immunity

Alexandria doubles down on decadeslong Seattle biotech bet with Mercer Mega Block deal

How Microsoft and Adaptive Biotech became a single team to build groundbreaking AI diagnostic

Shares of Gatesbacked Vir Bio tumble after 143M IPO to fund infectious disease efforts

3 leadership lessons from Adaptive Biotechnologies CEO Chad Robins

The voters will see you now: The finalists for Health Innovation of the Year at the GeekWire Awards

Adaptive Biotechnologies CEO Chad Robins on the power of mom and being a good listener

Life sciences startups in Eastern Washington find a welcoming ecosystem away from big cities

Adaptive Biotechnologies set to go public with valuation above 2B in biggest biotech IPO of 2019

GeekWire Awards: Vote for Deal of the Year the top tech acquisition or IPO in the Pacific NW

Tech Moves: Qualtrics hires Microsoft vet Amazon voice tech leader steps down Future For Us founders start new roles

Adaptive Biotech pushes ahead with new Seattle HQ showing strength of life sciences industry

FDA approves Adaptive Biotechs tool to track potential cancer relapses

Adaptive Biotechnologies stock soars 90 after ringing Nasdaq opening bell following 300M IPO

The search for a COVID19 cure: Amgen and Adaptive Biotech partner in quest for new drug

Microsoft and Adaptive launch quest for new COVID19 test seek 1k people for immune study

Adaptive Biotechnologies and Microsoft team up to track coronavirusfighting cells

Tech Moves: F5 Networks lands former Marketo and JP Morgan execs AI2 adds managing director Groupon snags REI vet and more

Microsoft and Adaptive Biotechnologies partner to study immune response to COVID19

Tech Moves: Google snags Georgia Tech AI professor Apptio hires exec from AWS The Riveter names Portland leader and more

Adaptive Biotechnologies beats estimates with Q3 revenue of 261M as shares rise 6

Industry slowdown hits Adaptive Biotechs bottom line as COVID immune initiatives show progress

Adaptive Biotech revenue rises 65 to 21M loss widens amid big COVID19 immune partnerships

Tech Moves: Smartsheet lands its first CMO Eatsa hires former Starbucks digital exec and more

Oisn raises 5M to develop treatments for zombie cells associated with agerelated diseases

Adaptive Biotechnologies will sell 8M shares to accelerate drug development

Tech Moves: ExJuno CEO Hans Bishop takes over at Grail Amazon Business chief departs Shyft cofounder jumps to Ally and more

Eye on autism: Inside the quest to develop an objective test for a disorder that impacts millions

Adaptive Biotechs deal with Amgen influenced by belief that COVID19 may return seasonally like flu

Adaptive Biotechnologies files for 230M IPO banking on big Microsoft and Genentech deals

Seattle techs extraordinary year: These are the stories well remember in the business of innovation

Adaptive and Illumina to make immune sequencing kits for labs streamlining the detection of disease

How these entrepreneurs use phone calls to gain an edge in the digital age

Adaptive Biotechnologies plans to sell up to 92M shares revenue grew 52 in 2019

Adaptive Biotechnologies signs blockbuster deal with Genentech for personalized cancer treatments worth up to 2 billion

Adaptive Biotechnologies cofounder leaves Fred Hutch IPO filing warned of IP risks from dual roles